Evidence map›Paper›PMID 23589410›Full record

ArticleJournal of geriatric psychiatry and neurology2013

Barriers to mental health care utilization in Parkinson's disease.

Roseanne D Dobkin, Jade Tiu Rubino, Jill Friedman, Lesley A Allen, Michael A Gara, Matthew Menza

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of geriatric psychiatry and neurology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01167608 (Barriers to Mental Healthcare Utilization in Parkinson's Disease), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01167608 completednot on this map

Barriers to Mental Healthcare Utilization in Parkinson's Disease

TypeobservationalSponsorRutgers, The State University of New JerseyRan2010 to 2013Enrolled883ConditionsParkinson's Disease, Depression, AnxietyArmsNo Intervention. This is a cross-sectional survey study.
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Efficacy of cognitive behavioral therapy for anxiety and depression in Parkinson's disease patients: an updated systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment.Movement disorders : official journal of the Movement Disorder Society · 2021
    Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Bridging the Rural Mental Health Gap: Telehealth Delivery of Specialized CBT and MBCT for Veterans With Parkinson's Disease.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Basal ganglia theta power indexes trait anxiety in people with Parkinson's disease.medRxiv : the preprint server for health sciences · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roseanne D DobkinDepartment of Psychiatry, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA. dobkinro@umdnj.edu
Jade Tiu Rubino
Jill Friedman
Lesley A Allen
Michael A Gara
Matthew Menza

Funding

Treating Depression in Parkinson's Disease: A New MethodK23NS052155 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI DOBKIN, ROSEANNE D · 2007 to 2011
$957k
NINDS NIH HHS 1 K23 NS052155-01A2NINDS NIH HHS K23 NS052155
6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is frequently complicated by co-occurring psychiatric problems such as depression and anxiety that negatively affect the course and management of the illness. Yet, in most cases, these psychiatric comorbidities are neither recognized nor treated to remission. The primary purpose of this study was to identify and describe barriers to mental health care utilization for people with PD. Secondary objectives included the assessment of attitudes and preferences regarding the need for mental health services in the PD community and the acceptability of telehealth interventions as a method for improving access and quality of care.

methodsA total of 769 people with PD completed an anonymous cross-sectional questionnaire assessing barriers to mental health care utilization in this medical population. Respondents were drawn from a national sample.

resultsCommonly endorsed barriers to mental health care utilization in PD reflect the patients' incomplete understanding of mental health problems, access issues, and illness-specific concerns, as well as the inadequate screening and detection of psychiatric complications by medical providers and the need for more effective treatments in this medical population. Several demographic, medical, and psychiatric variables also influenced the likelihood of accessing mental health care. Interest in telehealth approaches to mental health treatment was high and, in several instances, correlated with perceived barriers to mental health care utilization.

conclusionsPeople with PD may encounter a multitude of barriers that impede their pursuit of mental health care. Clinical implications are discussed and further research is needed to replicate and extend these findings.

Indexed as

Health Services AccessibilityCross-Sectional StudiesFemaleHumansMaleMental DisordersMental Health ServicesMiddle AgedNeeds AssessmentParkinson DiseaseSurveys and QuestionnairesTelemedicineanxietybarriersdepressionmental health care utilizationParkinson’s disease

Identifiers

PMID23589410
PMCPMC3644337
OpenAlexW2153659555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.